Drug intelligence / Profile preview

Bliss's Sulfur Ointment

Development stage: Unknown
Lead developer: Greenlife Pharmaceuticals
Modality: Small Molecules
Administration: Topical

Overview

Bliss's Sulfur Ointment is a topical small molecule generic drug developed and marketed by Greenlife Pharmaceuticals, a Nigerian pharmaceutical company. The active ingredient is sulfur, formulated as an ointment for the treatment of various skin conditions. It possesses keratolytic, antibacterial, and antifungal properties, making it effective against scabies, seborrheic dermatitis, and acne vulgaris. It is also indicated for chronic conditions such as psoriasis, ringworm, and lupus erythematosus. The product is manufactured through Greenlife's Indian partner, Bliss GVS Pharma, and is widely available in the West African market.

Brand names: Bliss's Sulfur Ointment
Other names: Sulfur ointment

Beyond the preview

Go deeper on Bliss's Sulfur Ointment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bliss's Sulfur Ointment.

Explore the full profile